Single nucleotide polymorphism discovery and functional assessment of variation in the UDP-glucuronosyltransferase 2B7 gene.
about
Interindividual variability in pharmacokinetics of generic nucleoside reverse transcriptase inhibitors in TB/HIV-coinfected Ghanaian patients: UGT2B7*1c is associated with faster zidovudine clearance and glucuronidationThe influence of UGT polymorphisms as biomarkers in solid organ transplantationInfluence of host genetic factors on efavirenz plasma and intracellular pharmacokinetics in HIV-1-infected patientsCodeine and Morphine MetabolismTolerance and withdrawal from prolonged opioid use in critically ill children.Interindividual variability in hepatic drug glucuronidation: studies into the role of age, sex, enzyme inducers, and genetic polymorphism using the human liver bank as a model system.Update on the Genetic Polymorphisms of Drug-Metabolizing Enzymes in Antiepileptic Drug Therapy.UGT2B7 is not expressed in normal breast.Genetic factors affecting gene transcription and catalytic activity of UDP-glucuronosyltransferases in human liverIn vitro and in vivo oxidative metabolism and glucuronidation of anastrozole.Identifying genomic and developmental causes of adverse drug reactions in children.Contribution of N-glucuronidation to efavirenz elimination in vivo in the basal and rifampin-induced metabolism of efavirenz.Uridine 5'-diphospho-glucuronosyltransferase genetic polymorphisms and response to cancer chemotherapy.UGT genomic diversity: beyond gene duplication.Chemokine (C-C motif) receptor 5 -2459 genotype in patients receiving highly active antiretroviral therapy: race-specific influence on virologic successImpact of UGT2B7 His268Tyr polymorphism on the outcome of adjuvant epirubicin treatment in breast cancer.Associations of UDP-glucuronosyltransferases polymorphisms with mycophenolate mofetil pharmacokinetics in Chinese renal transplant patientsPharmacogenetics of drug-metabolizing enzymes in US Hispanics.Worldwide variation in human drug-metabolism enzyme genes CYP2B6 and UGT2B7: implications for HIV/AIDS treatment.Pharmacogenetics of analgesic drugsSNP discovery, expression and cis-regulatory variation in the UGT2B genes.Impact of the CYP2C8 *3 polymorphism on the drug-drug interaction between gemfibrozil and pioglitazone.Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy.Profiling serum bile acid glucuronides in humans: gender divergences, genetic determinants, and response to fenofibrate.The use of allelic imbalance to ascertain cis-regulation for human UGT2B7 in vivoFunctional significance of UDP-glucuronosyltransferase variants in the metabolism of active tamoxifen metabolitesSpecies and inter-individual differences in metabolic capacity of di(2-ethylhexyl)phthalate (DEHP) between human and mouse liversCharacterization of Contributing Factors to Variability in Morphine Clearance Through PBPK Modeling Implemented With OCT1 Transporter.Developmental pharmacogenomics.Morphine metabolism, transport and brain disposition.Opioid genetics: the key to personalized pain control?Gastric cancer pharmacogenetics: progress or old tripe?Role of pharmacogenetics of drug-metabolizing enzymes in treating osteosarcoma.Influence of valproic acid concentration and polymorphism of UGT1A4*3, UGT2B7 -161C > T and UGT2B7*2 on serum concentration of lamotrigine in Chinese epileptic children.Pharmacogenetics of UGT1A4, UGT2B7 and UGT2B15 and Their Influence on Tamoxifen Disposition in Asian Breast Cancer Patients.Unravelling the transcriptomic landscape of the major phase II UDP-glucuronosyltransferase drug metabolizing pathway using targeted RNA sequencing.Association between UGT2B7 gene polymorphisms and fentanyl sensitivity in patients undergoing painful orthognathic surgery.Early post-traumatic seizures are associated with valproic acid plasma concentrations and UGT1A6/CYP2C9 genetic polymorphisms in patients with severe traumatic brain injury.Rash and multiorgan dysfunction following lamotrigine: could genetic be involved?Effect of UGT2B7 genotypes on plasma concentration of valproic acid: a meta-analysis.
P2860
Q24648578-37E4E32D-C950-40B8-AA07-B0AD16D8D80FQ27009825-E47DB608-8BA3-4808-811C-2DD769599CDEQ28293875-0AB35C84-7C21-4369-9C4B-69FBEA38B8F4Q30230768-19F9CD43-EDC4-45A6-BA43-83E709F2B7B5Q30428413-3360F7DD-716F-4DBA-90FE-2E86C331830FQ33451969-A2D6CF69-FBBB-4D53-873B-3914BB15777AQ33664128-79154FD6-FB94-460C-8859-DE109DFDCC2FQ34065012-863F1048-A3F9-4BEA-A0FC-E090479B150EQ34211851-D3433A22-4AD5-42D6-9F95-EF60E7E08BEDQ34457429-13E44417-1689-4139-BC0E-21940BA9E752Q34603032-A9298F28-4D66-4DF1-B687-71808A6BBE56Q34737523-49FA2D2F-2C68-4070-ADB4-2DBD5326E801Q35008045-15478ADE-13A4-4A9B-89B5-7EF8590AFCECQ35009521-6DDF20EF-9E76-4F3C-8FE1-814BD59513AEQ35043700-67830BBA-4AB3-486D-8163-D7BDF7FC4016Q35558084-FFDE51A2-FF98-4824-B5DC-9B95AB9FE1E8Q35578549-95555B58-0430-4E09-996E-8FB64C326A8BQ35661209-A7E8FC14-1AAD-4EC1-9AE9-F9C388DAD312Q36079108-6729A839-7EF6-41C0-B2B4-99BFA777A376Q36110592-7FAE9A45-5C5D-4B8D-A036-D07D4DE838C8Q36276855-81914120-D6AB-4423-B0F7-C4E1B193A322Q36562502-FAC67F21-8245-4F40-8EC2-3A5D906598D8Q36603317-0E124915-65AB-493F-A9C6-C4E8208E5DC0Q36834217-D28968A9-ADC9-4249-B928-46D2ADE5A7E8Q37107040-288328DD-8F6A-48E6-AB7E-186258C93D82Q37195375-2BFC6878-79DD-43BF-BFD5-A7BC71435830Q37620247-FA1E150C-2578-4815-8EE8-FDC2E79EF805Q37660713-46A5492F-DB1E-4CA4-88A6-CAB550D78A4CQ37841723-3D19D0A2-7116-43E0-90B6-DA0750BCD366Q37970914-EB4C96B5-5D0B-480A-BA69-77FAB1829057Q38025200-668C4946-4D34-4672-9435-4EF062D82AC2Q38120288-BCC22321-CBCB-4587-A3AD-CD99700C35BCQ38533459-ABD82677-AEF8-4A7E-A48B-CC619ABCE0EDQ40612167-EBBDBC8B-DCCB-4D13-B615-B13D2959EE17Q40789462-2F12584D-7D72-4CBE-A92C-88571A56819AQ41079678-B9731812-2ECE-4EE4-8BE9-0880B0F7E0E5Q41087224-AFE5CAFC-3E65-421D-86CB-04DB36E90D43Q41542027-93DD6E03-8D9E-4C9E-A5B8-30108AC61B37Q41587506-A5E555F2-410E-40F3-B664-18FB7B5CBCE8Q47306035-6D3675F7-98C1-4E26-9C96-2B43705203A7
P2860
Single nucleotide polymorphism discovery and functional assessment of variation in the UDP-glucuronosyltransferase 2B7 gene.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Single nucleotide polymorphism ...... curonosyltransferase 2B7 gene.
@en
Single nucleotide polymorphism ...... curonosyltransferase 2B7 gene.
@nl
type
label
Single nucleotide polymorphism ...... curonosyltransferase 2B7 gene.
@en
Single nucleotide polymorphism ...... curonosyltransferase 2B7 gene.
@nl
prefLabel
Single nucleotide polymorphism ...... curonosyltransferase 2B7 gene.
@en
Single nucleotide polymorphism ...... curonosyltransferase 2B7 gene.
@nl
P2093
P2860
P50
P1476
Single nucleotide polymorphism ...... curonosyltransferase 2B7 gene.
@en
P2093
Donna Fackenthal
Federico Innocenti
Jacqueline Ramírez
Peixian Chen
Snezana Mirkov
Xiaolin Wu
P2860
P304
P356
10.1097/FPC.0B013E3283037FE4
P577
2008-08-01T00:00:00Z